A Dutch approach to methicillin-resistant Staphylococcus aureus.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology ·Vol. 18 ·No. 7 ·1999-07-00 ·Pages 461-6

Verhoef J, Beaujean D, Blok H, Baars A, Meyler A, van der Werken C, Weersink A

Abstract

暂无摘要

MeSH Terms

Cost-Benefit Analysis Delivery of Health Care/legislation & jurisprudence Gene Frequency Guidelines as Topic Humans Methicillin/pharmacology,therapeutic use Methicillin Resistance/genetics Netherlands/epidemiology Penicillins/pharmacology,therapeutic use Staphylococcal Infections/epidemiology,prevention & control Staphylococcus aureus/drug effects,genetics

Chemicals

Penicillins Methicillin

Authors & Affiliations

7 authors, click to expand affiliations / ORCID

Verhoef J

Beaujean D

Blok H

Baars A

Meyler A

van der Werken C

Weersink A

Article Info

Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Abbr.

Eur J Clin Microbiol Infect Dis

ISSN

0934-9723

DOI

10.1007/s100960050324

Published

1999-07-00

Pages

461-6

Language

English

Region

Germany

NLM ID

8804297

Subset

External Links

PubMed source DOI: 10.1007/s100960050324 View journal details

Analysis Services

A Dutch approach to methicillin-resistant Staphylococcus aureus.

Contact

WeChat Official Account